Cisplatin News and Research

RSS
Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Study uncovers new protein complex that shields broken DNA ends

Study uncovers new protein complex that shields broken DNA ends

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Pediatric neuroblastoma patients have high risk of long-term psychological impairment

Pediatric neuroblastoma patients have high risk of long-term psychological impairment

Colorado researchers suggest new combination therapy for advanced head and neck cancer

Colorado researchers suggest new combination therapy for advanced head and neck cancer

International researchers succeed in stopping growth of mesothelioma in model animals

International researchers succeed in stopping growth of mesothelioma in model animals

Studies show hemp's potential for treating ovarian cancer

Studies show hemp's potential for treating ovarian cancer

Scientists discover new family of promising silver-based anti-cancer drugs

Scientists discover new family of promising silver-based anti-cancer drugs

Treating metastatic breast cancer with immunotherapy

Treating metastatic breast cancer with immunotherapy

Potential new principle for treatment of multiple forms of cancer

Potential new principle for treatment of multiple forms of cancer

Light-activated cancer drugs without toxic side effects are closer to becoming reality

Light-activated cancer drugs without toxic side effects are closer to becoming reality

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Unique reusable treatment effectively destroys cancer cells

Unique reusable treatment effectively destroys cancer cells

Loss of specific protein makes breast cancers more aggressive, resistant to chemotherapy

Loss of specific protein makes breast cancers more aggressive, resistant to chemotherapy

Study finds new way to explain hearing loss caused by cancer drug

Study finds new way to explain hearing loss caused by cancer drug

Mutational patterns could identify breast cancer patients most likely to respond to platinum-based chemotherapy

Mutational patterns could identify breast cancer patients most likely to respond to platinum-based chemotherapy

Clearance of cancer cell debris via pro-resolving mediators can prevent tumor recurrence

Clearance of cancer cell debris via pro-resolving mediators can prevent tumor recurrence

Researchers develop computer program to find new indications for old drugs

Researchers develop computer program to find new indications for old drugs

Novel approach could help predict how well patients respond to cancer treatment

Novel approach could help predict how well patients respond to cancer treatment

Scientists use BR nanoparticles to develop photoacoustic imaging and photothermal cancer therapy

Scientists use BR nanoparticles to develop photoacoustic imaging and photothermal cancer therapy